SEC Form 4 · accession 0001127602-18-009475

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 28, 2018

Accepted (ET)

Mar 2, 2018 · 7:32 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 28, 2018	S	100	$108.13	D	310,340	D
Common Stock	Feb 28, 2018	S	100	$108.145	D	310,240	D
Common Stock	Feb 28, 2018	S	100	$108.155	D	310,140	D
Common Stock	Feb 28, 2018	S	600	$108.17	D	309,540	D
Common Stock	Feb 28, 2018	S	100	$108.175	D	309,440	D
Common Stock	Feb 28, 2018	S	220	$108.18	D	309,220	D
Common Stock	Feb 28, 2018	S	80	$108.19	D	309,140	D
Common Stock	Feb 28, 2018	S	200	$108.20	D	308,940	D
Common Stock	Feb 28, 2018	S	100	$108.21	D	308,840	D
Common Stock	Feb 28, 2018	S	300	$108.22	D	308,540	D
Common Stock	Feb 28, 2018	S	200	$108.225	D	308,340	D
Common Stock	Feb 28, 2018	S	100	$108.23	D	308,240	D
Common Stock	Feb 28, 2018	S	200	$108.24	D	308,040	D
Common Stock	Feb 28, 2018	S	100	$108.245	D	307,940	D
Common Stock	Feb 28, 2018	S	100	$108.25	D	307,840	D
Common Stock	Feb 28, 2018	S	100	$108.27	D	307,740	D
Common Stock	Feb 28, 2018	S	100	$108.275	D	307,640	D
Common Stock	Feb 28, 2018	S	100	$108.28	D	307,540	D
Common Stock	Feb 28, 2018	S	100	$108.29	D	307,440	D
Common Stock	Feb 28, 2018	S	200	$108.295	D	307,240	D
Common Stock	Feb 28, 2018	S	300	$108.30	D	306,940	D
Common Stock	Feb 28, 2018	S	200	$108.31	D	306,740	D
Common Stock	Feb 28, 2018	S	100	$108.32	D	306,640	D
Common Stock	Feb 28, 2018	S	598	$108.33	D	306,042	D

No Table II lines on this filing.